This is the second receptor engaged by Tirzepatide (the "twincretin" target)
While not an active malignancy, the peptides mechanisms for promoting cell growth and blood vessel formation are a theoretical concern
Stahl quote: "Follow the FDA label and never get anybody better" [22:10] When GLP-1s aren't appropriate [24:01] Case study: patient on paliperidone gaining weight despite tirzepatide [25:52] Discovery of nucleus tractus solitaris [28:26] The "are we allowed to prescribe this?" debate [29:10] Valproic acid, propranolol, and scope of practice [30:01] Bipolar disorder, obesity, and mood episode frequency [30:49] Moving beyond the monoamine hypothesis [31:19] UK paper: no proof depression is serotonin deficiency [33:23] Alternative treatments: TMS, ketamine, GLP-1s [34:03] Dr
Avoid exposing reconstituted vials to direct sunlight or temperature fluctuations, which can degrade the peptide over time
(12) These challenges lengthen hospital stays, increase the need for readmissions or revision procedures, and impair long-term functional outcomes
Modulation of the energy metabolism inhibits plasmacytoid dendritic cell activation and delays onset of autoantibody production in murine models of systemic lupus erythematosus